Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1987;98:119–127.

Antiplatelet agents and diabetic vascular disease.

J A Colwell
PMCID: PMC2279735  PMID: 3303615

Full text

PDF
119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bern M. M. Platelet functions in diabetes mellitus. Diabetes. 1978 Mar;27(3):342–350. doi: 10.2337/diab.27.3.342. [DOI] [PubMed] [Google Scholar]
  2. Colwell J. A., Bingham S. F., Abraira C., Anderson J. W., Comstock J. P., Kwaan H. C., Nuttall F. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Diabetes Care. 1986 Mar-Apr;9(2):140–148. doi: 10.2337/diacare.9.2.140. [DOI] [PubMed] [Google Scholar]
  3. Colwell J. A., Bingham S. F., Abraira C., Anderson J. W., Kwaan H. C. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics. Control Clin Trials. 1984 Jun;5(2):165–183. doi: 10.1016/0197-2456(84)90122-3. [DOI] [PubMed] [Google Scholar]
  4. Colwell J. A., Halushka P. V. Platelet function in diabetes mellitus. Br J Haematol. 1980 Apr;44(4):521–526. doi: 10.1111/j.1365-2141.1980.tb08705.x. [DOI] [PubMed] [Google Scholar]
  5. Colwell J. A., Lopes-Virella M., Halushka P. V. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care. 1981 Jan-Feb;4(1):121–133. doi: 10.2337/diacare.4.1.121. [DOI] [PubMed] [Google Scholar]
  6. Colwell J. A., Sagel J., Crook L., Chambers A., Laimins M. Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with an without vascular disease. Metabolism. 1977 Mar;26(3):279–285. doi: 10.1016/0026-0495(77)90074-9. [DOI] [PubMed] [Google Scholar]
  7. Colwell J. A., Winocour P. D., Lopes-Virella M., Halushka P. V. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med. 1983 Nov 30;75(5B):67–80. doi: 10.1016/0002-9343(83)90256-5. [DOI] [PubMed] [Google Scholar]
  8. Garcia M. J., McNamara P. M., Gordon T., Kannel W. B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974 Feb;23(2):105–111. doi: 10.2337/diab.23.2.105. [DOI] [PubMed] [Google Scholar]
  9. Halushka P. V., Rogers R. C., Loadholt C. B., Colwell J. A. Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med. 1981 Jan;97(1):87–96. [PubMed] [Google Scholar]
  10. Hanson S. R., Harker L. A., Bjornsson T. D. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. J Clin Invest. 1985 May;75(5):1591–1599. doi: 10.1172/JCI111865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Honour A. J., Hockaday T. D., Mann J. I. The synergistic effect of aspirin and dipyridamole upon platelet thrombi in living blood vessels. Br J Exp Pathol. 1977 Jun;58(3):268–272. [PMC free article] [PubMed] [Google Scholar]
  12. Kwaan H. C., Colwell J. A., Cruz S., Suwanwela N., Dobbie J. G. Increased platelet aggregation in diabetes mellitus. J Lab Clin Med. 1972 Aug;80(2):236–246. [PubMed] [Google Scholar]
  13. Kwaan H. C., Colwell J. A., Suwanwela N. Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation. Diabetes. 1972 Feb;21(2):108–113. doi: 10.2337/diab.21.2.108. [DOI] [PubMed] [Google Scholar]
  14. Mustard J. F. The Gordon Wilson lecture: function of blood platelets and their role in thrombosis. Trans Am Clin Climatol Assoc. 1976;87:104–127. [PMC free article] [PubMed] [Google Scholar]
  15. Ross R., Glomset J. A. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med. 1976 Aug 12;295(7):369–377. doi: 10.1056/NEJM197608122950707. [DOI] [PubMed] [Google Scholar]
  16. Sagel J., Colwell J. A., Crook L., Laimins M. Increased platelet aggregation in early diabetus mellitus. Ann Intern Med. 1975 Jun;82(6):733–738. doi: 10.7326/0003-4819-82-6-733. [DOI] [PubMed] [Google Scholar]
  17. Van Zile J., Kilpatrick M., Laimins M., Sagel J., Colwell J., Virella G. Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients. Diabetes. 1981 Jul;30(7):575–579. doi: 10.2337/diab.30.7.575. [DOI] [PubMed] [Google Scholar]
  18. Winocour P. D., Laimins M., Colwell J. A. Platelet survival in streptozotocin-induced diabetic rats. Thromb Haemost. 1984 Jul 29;51(3):307–312. [PubMed] [Google Scholar]
  19. Winocour P. D., Lopes-Virella M., Laimins M., Colwell J. A. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. J Lab Clin Med. 1983 Nov;102(5):795–804. [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES